0001628280-24-028357.txt : 20240614
0001628280-24-028357.hdr.sgml : 20240614
20240614174659
ACCESSION NUMBER: 0001628280-24-028357
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Azelby Robert
CENTRAL INDEX KEY: 0001656998
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39071
FILM NUMBER: 241046248
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVE. NORTH, STE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADC Therapeutics SA
CENTRAL INDEX KEY: 0001771910
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BIOPOLE
STREET 2: ROUTE DE LA CORNICHE 3B
CITY: EPALINGES
STATE: V8
ZIP: 1066
BUSINESS PHONE: 41 21 653 02 00
MAIL ADDRESS:
STREET 1: BIOPOLE
STREET 2: ROUTE DE LA CORNICHE 3B
CITY: EPALINGES
STATE: V8
ZIP: 1066
4
1
wk-form4_1718401609.xml
FORM 4
X0508
4
2024-06-13
0
0001771910
ADC Therapeutics SA
ADCT
0001656998
Azelby Robert
430 MOUNTAIN AVENUE, SUITE 404
NEW PROVIDENCE
NJ
07974
1
0
0
0
0
Common Shares
2024-06-13
4
A
0
40000
0
A
60000
D
Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Lisa Kallebo, as Attorney-in-Fact for Robert Azelby
2024-06-14